{"id":680,"date":"2025-03-03T21:21:50","date_gmt":"2025-03-03T21:21:50","guid":{"rendered":"https:\/\/perfusfind.com\/ic\/?p=680"},"modified":"2025-03-03T21:22:35","modified_gmt":"2025-03-03T21:22:35","slug":"the-net-effect-neutrophil-extracellular-traps-a-potential-key-component-of-the-dysregulated-host-immune-response-in-sepsis","status":"publish","type":"post","link":"https:\/\/perfusfind.com\/ic\/index.php\/2025\/03\/03\/the-net-effect-neutrophil-extracellular-traps-a-potential-key-component-of-the-dysregulated-host-immune-response-in-sepsis\/","title":{"rendered":"\u201cThe NET effect\u201d: Neutrophil extracellular traps\u2014a potential key component of the dysregulated host immune response in sepsis"},"content":{"rendered":"

Abstract<\/h2>\n
\n

Neutrophils release neutrophil extracellular traps (NETs) as part of a healthy host immune response. NETs physically trap and kill pathogens as well as activating and facilitating crosstalk between immune cells and complement. Excessive or inadequately resolved NETs are implicated in the underlying pathophysiology of sepsis and other inflammatory diseases, including amplification of the inflammatory response and inducing thrombotic complications. Here, we review the growing evidence implicating neutrophils and NETs as central players in the dysregulated host immune response. We discuss potential strategies for modifying NETs to improve patient outcomes and the need for careful patient selection.<\/p>\n

Key Points<\/h3>\n
    \n
  1. NETs and Host Defense Mechanisms:<\/strong> NETs, composed of chromatin and antimicrobial proteins, trap and neutralize pathogens while activating immune responses. However, excessive NET formation can lead to tissue damage, endothelial dysfunction, and exacerbation of inflammation.<\/li>\n
  2. NETs in Immunothrombosis:<\/strong> Immunothrombosis integrates immune and coagulation responses to control pathogens, but unchecked activation leads to widespread thromboinflammation, contributing to organ dysfunction in sepsis. NETs provide a scaffold for thrombin generation and platelet aggregation, linking inflammation and coagulopathy.<\/li>\n
  3. Dysregulated NET Clearance in Sepsis:<\/strong> Impaired clearance of NETs and damage-associated molecular patterns (DAMPs) contributes to the persistence of inflammation and microvascular thrombosis in sepsis. This can worsen endothelial injury and promote disseminated intravascular coagulation (DIC).<\/li>\n
  4. Mechanisms of NETosis:<\/strong> Three forms of NETosis\u2014suicidal, vital, and mitochondrial\u2014differ in their pathways and implications. Suicidal NETosis, a form of cell death, depletes neutrophils and contributes to immunosuppression, while vital and mitochondrial NETosis allow continued neutrophil function but sustain inflammatory responses.<\/li>\n
  5. NETs as a Source of DAMPs:<\/strong> NETosis releases histones, DNA, and nucleosomes into circulation, amplifying immune responses and further activating complement and coagulation pathways. These DAMPs perpetuate a cycle of inflammation, endothelial damage, and organ failure in sepsis.<\/li>\n
  6. NET-Complement Interactions:<\/strong> NETs and complement proteins engage in a bidirectional interaction that exacerbates inflammation. NET-bound proteases activate complement components, while complement activation promotes further NET formation, leading to a self-perpetuating cycle of immune dysregulation.<\/li>\n
  7. Microbial Evasion of NETs:<\/strong> Pathogens have evolved mechanisms to evade NET-mediated killing, such as producing DNases that degrade NET structures, modifying surface proteins to prevent NET binding, and forming biofilms for protection. This contributes to persistent infections and worsens outcomes in sepsis.<\/li>\n
  8. Potential Therapeutic Targets:<\/strong> Strategies to modify NET formation include inhibiting NETosis pathways (e.g., PAD4 inhibitors), enhancing NET degradation (e.g., recombinant DNase I), and targeting NET components such as histones and neutrophil elastase. DNase therapy has shown promise in reducing NET-driven thrombosis and inflammation.<\/li>\n
  9. Challenges in NET-Directed Therapies:<\/strong> While targeting NETs offers potential therapeutic benefits, over-suppression may impair pathogen defense. A balanced approach is needed to prevent excessive NET formation while preserving their protective function. Biomarkers for NET activity could aid in patient selection and treatment personalization.<\/li>\n
  10. Future Directions and Research Needs:<\/strong> Further investigation is required to refine NET-targeted therapies, explore their role in other inflammatory diseases, and establish their impact on clinical outcomes in sepsis. The development of NET-specific biomarkers and individualized treatment strategies may help optimize patient care.<\/li>\n<\/ol>\n

    ACCESS FULL ARTICLE HERE<\/strong><\/a><\/p>\n

    Open Access<\/b>\u00a0This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit\u00a0http:\/\/creativecommons.org\/licenses\/by\/4.0\/<\/a>.<\/p>\n